Fontana M - Search Results

1

[The pivotal role of the pathologist in transplantation].

Rotman S, Fontana M, Seydoux C, Venetz JP, Aubert JD, Pascual M. Rotman S, et al. Among authors: fontana m. Rev Med Suisse. 2008 Feb 20;4(145):480-3. Rev Med Suisse. 2008. PMID: 18376526 French.

2

[Liver transplantation: new organ allocation system in Switzerland].

Fontana M, Giostra E, Pilon N, Michetti P, Mentha G, Pascual M, Moradpour D. Fontana M, et al. Rev Med Suisse. 2008 Jan 23;4(141):221-3. Rev Med Suisse. 2008. PMID: 18335887 French.

3

Efficacy and safety of universal valganciclovir prophylaxis combined with a tacrolimus/mycophenolate-based regimen in kidney transplantation.

Manuel O, Venetz JP, Fellay J, Wasserfallen JB, Sturzenegger N, Fontana M, Matter M, Meylan PR, Pascual M. Manuel O, et al. Among authors: fontana m. Swiss Med Wkly. 2007 Dec 1;137(47-48):669-76. doi: 10.4414/smw.2007.11961. Swiss Med Wkly. 2007. PMID: 18058275 Free article.

4

Influence of ABCB1 genetic polymorphisms on cyclosporine intracellular concentration in transplant recipients.

Crettol S, Venetz JP, Fontana M, Aubert JD, Ansermot N, Fathi M, Pascual M, Eap CB. Crettol S, et al. Among authors: fontana m. Pharmacogenet Genomics. 2008 Apr;18(4):307-15. doi: 10.1097/FPC.0b013e3282f7046f. Pharmacogenet Genomics. 2008. PMID: 18334915

5

CYP3A7, CYP3A5, CYP3A4, and ABCB1 genetic polymorphisms, cyclosporine concentration, and dose requirement in transplant recipients.

Crettol S, Venetz JP, Fontana M, Aubert JD, Pascual M, Eap CB. Crettol S, et al. Among authors: fontana m. Ther Drug Monit. 2008 Dec;30(6):689-99. doi: 10.1097/FTD.0b013e31818a2a60. Ther Drug Monit. 2008. PMID: 18978522

6

Oral valganciclovir for cytomegalovirus colitis after liver transplantation.

Manuel O, Meylan PR, Rotman S, Fontana M, Moradpour D, Pascual M. Manuel O, et al. Among authors: fontana m. Transplantation. 2007 Jan 27;83(2):239-40. doi: 10.1097/01.tp.0000242138.33261.ef. Transplantation. 2007. PMID: 17264825 No abstract available.

7

Combined antiviral therapy for recurrent hepatitis C virus after liver transplantation.

Fontana M, Ciuffreda D, Moradpour D, Pascual M. Fontana M, et al. Transplantation. 2007 Feb 27;83(4):525-6. doi: 10.1097/01.tp.0000251974.97869.6f. Transplantation. 2007. PMID: 17318091 No abstract available.

8

Prevalence of anti-HLA antibodies after liver transplantation.

Fontana M, Moradpour D, Aubert V, Pantaleo G, Pascual M. Fontana M, et al. Transpl Int. 2010 Aug;23(8):858-9. doi: 10.1111/j.1432-2277.2009.01022.x. Epub 2009 Dec 14. Transpl Int. 2010. PMID: 20003031 Free article. No abstract available.

9

[Management of chronic viral hepatitis].

Pache I, Mondada D, Moradpour D, Fontana M. Pache I, et al. Among authors: fontana m. Rev Med Suisse. 2007 Jan 24;3(95):215, 217-8, 221-3. Rev Med Suisse. 2007. PMID: 17357690 Review. French.

10

Injection drug use before and after liver transplantation: a retrospective multicenter analysis on incidence and outcome.

De Gottardi A, Hilleret MN, Gelez P, La Mura V, Guillaud O, Majno P, Hadengue A, Morel P, Zarski JP, Fontana M, Moradpour D, Mentha G, Boillot O, Leroy V, Giostra E, Dumortier J. De Gottardi A, et al. Among authors: fontana m. Clin Transplant. 2010 Jul-Aug;24(4):564-71. doi: 10.1111/j.1399-0012.2009.01121.x. Clin Transplant. 2010. PMID: 19849705

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,537 results

Search Page

Filters